Physician

Joel H Datloff, MD

According to 2025 Medicare claims, Joel Datloff, MD (NPI: 1477581817) practices dermatology in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Clark, WA. This provider's primary affiliated billing organization is DERMATOLOGY ASSOCIATES OF SOUTHWEST WASHINGTON, PLLC (NPI: 1992938906; TIN: 270688785) and primary practice location at 98664-2092.

Datloff's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 694 traditional Medicare patients, billed 3,617 HCPCS/CPT codes, and received $147,294 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,313 prescription claims across 469 beneficiaries totaling $717,242 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 58 records totaling $1,344. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $208,361 to $717,242. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	834	5,717	$175,764
2016	964	6,678	$190,350
2017	902	6,282	$189,616
2018	758	4,799	$147,227
2019	723	4,205	$132,024
2020	758	4,322	$164,510
2021	871	4,856	$186,460
2022	817	4,536	$167,468
2023	735	3,976	$151,380
2024	694	3,617	$147,294

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	398	1,081	$208,361
2016	376	1,002	$246,302
2017	373	983	$242,537
2018	379	988	$256,256
2019	332	903	$371,614
2020	391	1,095	$466,151
2021	426	1,230	$577,379
2022	421	1,208	$990,049
2023	454	1,233	$810,510
2024	469	1,313	$717,242

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	220	266	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	307	408	$64
17000	Destruction of precancer skin growth, 1 growth	284	426	$41
88305	Pathology examination of tissue using a microscope, intermediate complexity	230	320	$28
17003	Destruction of precancer skin growth, 2-14 growths	228	1,269	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cosentyx Sensoready (2 Pens)	Secukinumab	19	532	$147,498
Taltz Autoinjector	Ixekizumab	21	588	$144,450
Humira(Cf) Pen	Adalimumab	12	336	$81,738
Dupixent Syringe	Dupilumab	12	336	$44,904
Metronidazole	Metronidazole	76	2,570	$7,783

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	58	$1,344	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joel H. Datloff, MD?

Tedicare shows public-source Medicare data for Joel H. Datloff, MD (NPI 1477581817), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joel H. Datloff, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joel H. Datloff, MD?

Joel H. Datloff, MD is linked to DERMATOLOGY ASSOCIATES OF SOUTHWEST WASHINGTON, PLLC (billing NPI 1992938906) in the available physician profile data.

Does Joel H. Datloff, MD have Open Payments data?

Joel H. Datloff, MD has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.